Oskar Hansson
Impact in
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research
- Neurology top 0.02%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Neurological disorders and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 339
- Physiology 394
- Alzheimer's disease research and treatments 374
- Co-authors
- Kaj BlennowHenrik ZetterbergNiklas MattssonLennart MinthonErik StomrudSebastian PalmqvistElisabet LondosShorena Janelidze
- Journals
- Alzheimer s & Dementia (127 papers)Theoria (45 papers)Alzheimer s Research & Therapy (44 papers)Neurology (28 papers)Brain (26 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Oskar Hansson
760 papers receiving 39.2k citations
Hit Papers
Peers
Comparison fields: 5 of 226
- Psychiatry and Mental health 15.6k
- Neurology 7.1k
- Physiology 21.1k
- Biological Psychiatry 1.7k
- Neurology 6.6k
Countries citing papers authored by Oskar Hansson
This map shows the geographic impact of Oskar Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oskar Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oskar Hansson more than expected).
Fields of papers citing papers by Oskar Hansson
This network shows the impact of papers produced by Oskar Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oskar Hansson. The network helps show where Oskar Hansson may publish in the future.
Co-authors
The 25 scholars most cited alongside Oskar Hansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 3 | |
| 4 | evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease Hit paper breakdown → | 2025 | 40 |
| 5 | 2025 | 0 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 2 | |
| 8 | Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios Hit paper breakdown → | 2023 | 77 |
| 9 | 2023 | 1 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 37 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 25 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 6 | |
| 17 | 2019 | 1 | |
| 18 | Blood-based NfL Hit paper breakdown → | 2017 | 356 |
| 19 | 2016 | 130 | |
| 20 | Erratum: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study (Lancet Neurology (2006) 5 (228-34)) | 2006 | 0 |
About Oskar Hansson
Oskar Hansson is a scholar working on Psychiatry and Mental health, Physiology, Neurology, Neurology and Chemical Health and Safety, having authored 829 papers that have together received 40.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (374 papers), Dementia and Cognitive Impairment Research (339 papers), Parkinson's Disease Mechanisms and Treatments (94 papers), Functional Brain Connectivity Studies (76 papers), Advanced Neuroimaging Techniques and Applications (54 papers), Neurological Disease Mechanisms and Treatments (53 papers), Neurological disorders and treatments (39 papers) and Neuroinflammation and Neurodegeneration Mechanisms (37 papers). The work is most often cited by research in Psychiatry and Mental health (15.6k citations), Neurology (7.1k citations), Physiology (21.1k citations), Biological Psychiatry (1.7k citations) and Neurology (6.6k citations). Oskar Hansson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Kaj Blennow, Henrik Zetterberg, Niklas Mattsson, Lennart Minthon, Erik Stomrud, Sebastian Palmqvist, Elisabet Londos, Shorena Janelidze, Ruben Smith and Shorena Janelidze. Their work appears in journals such as Alzheimer s & Dementia, Theoria, Alzheimer s Research & Therapy, Neurology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.